Company
Alafair Biosciences
Soft-Tissue Protection Reimagined
Also known as Alafair Biosciences, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Customers
- Surgeons
- Legal name
- Alafair Biosciences, Inc.
- alafairbiosciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 19 September 2026
About
To redefine surgical healing with advanced biomaterials that prevent soft tissue tethering, support natural mobility, and empower surgeons to help patients reclaim optimal physical function.
Funding snapshot
- Total raised
- $7.2MSum of rounds, as of 2026-09-19Source (opens in a new tab)
- Latest round
- Series B, $7.2M2019
Funding rounds
- Series B
- $7.2M2019, Company stated
- Round, 2018
- $2.3M2018-09-28, SEC form D sold, 15 investors
- Round, 2017
- $965K2017-06-30, SEC form D sold, 9 investors
- Round, 2015
- $984K2015-10-05, SEC form D sold, 11 investors
- Round, 2014
- $1M2014-04-23, SEC form D sold, 1 investor
- Round, 2013
- $525K2013-07-26, SEC form D sold, 3 investors
- Round, 2011
- $702K2011-11-01, SEC form D sold, 14 investors
Products
- Hardware
- VersaCoat Flowable Hydrogel
- Hardware
- VersaWrap Hydrogel Sheet
Loading relationship preview